Nikkiso Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2017; Announces Interim Dividend for the Year Ending Dec. 31, 2017 Payable on September 5, 2017; Expects to Pay Year End Dividend for the Fiscal Year Ending December 31, 2017
August 06, 2017
Share
Nikkiso Co., Ltd. announced consolidated earnings results for the six months ended June 30, 2017. For the period, the consolidated company reported net sales of ¥63,306 million, operating profit of ¥353 million, ordinary income of ¥532 million, net profit attributable to owners of the parent of the company of ¥162 million or ¥2.28 per basic share and ¥2.02 per diluted share compared to net sales of ¥61,954 million, operating income of ¥1,986 million, ordinary loss of ¥248 million, net loss attributable to owners of the parent of the company of ¥455 million or ¥5.99 loss per basic share and nil for diluted share for the same period last year. Profit before income taxes was ¥651 million against ¥198 million a year ago.
The company announced interim dividend of ¥8.00 per share for the year ending Dec. 31, 2017 against ¥8.00 per share a year ago. The company will pay dividend on September 5, 2017.
The company expects to pay year end dividend of ¥8.00 per share for the fiscal year ending December 31, 2017.
For the fiscal year ending December 31, 2017, the consolidated company expects net sales of ¥140,000 million, operating income of ¥6,000 million, ordinary income of ¥5,500 million, net income of ¥4,500 million or net income per share of ¥63.21.
NIKKISO CO.,LTD. is a Japan-based company principally engaged in the manufacture and sale of industrial pumps, precision equipment and blood related products, among others. The Company operates in two business segments. Industrial Business segment conducts industrial business including the manufacture, sale and maintenance of industrial special pumps, as well as liquefied gas & industrial gas related equipment and devices. The Segment is also involved in precision equipment business, aerospace business and deep ultraviolet light emitting diode (LED) business. Medical Business segmentâs products are dialysis-related products including hemodialysis and peritoneal dialysis, such as artificial dialysis machines, dialyzers, blood circuits, and powder-type dialysis agents. The Segment also manufactures, sells and maintains products and medicines related to CRRT (acute blood purification therapy), artificial pancreas devices that manage blood glucose, and energy devices for microwave surgery.
Nikkiso Co., Ltd. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Consolidated Earnings Guidance for the Full Year Ending December 31, 2017; Announces Interim Dividend for the Year Ending Dec. 31, 2017 Payable on September 5, 2017; Expects to Pay Year End Dividend for the Fiscal Year Ending December 31, 2017